Skip to main content
Signal8

CollPlant Biotechnologies Ltd Form SCHEDULE 13D/A — Oct 8, 2026

Form SCHEDULE 13D/AFiled Oct 8, 2026, 10:54 AM ET0001213900-26-107784Original filing

Ami Sagy filed Amendment No. 5 to his Schedule 13D on CollPlant Biotechnologies, reporting beneficial ownership of 163,709 ordinary shares, or approximately 5.7% of the class. His percentage decreased solely because the issuer issued new shares since Amendment No. 4 in November 2025; he bought or sold nothing.

Key figures

Shares Owned
163709
Percent Owned
5.7%
Reverse Split Ratio
1-for-10
Shares Outstanding Basis
2866715
Reverse Split Effective Date
2026-09-04

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    CollPlant Biotechnologies Ltd Form SCHEDULE 13D/A — Oct 8, 2026: AI Analysis | Signal8